Do you want to read an article? Please log in or register.
Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function
Type 2 Diabetes
Related content
COMMENTED
Diabetes - General
Medicines for Treatment Intensification in Type 2 Diabetes and Type of Insulin in Type 1 and Type 2 Diabetes in Low-Resource Settings: Synopsis of the World Health Organization Guidelines on Second- and Third-Line Medicines and Type of Insulin for the Control of Blood Glucose Levels in Nonpregnant Adults With Diabetes Mellitus
Ann Intern Med.
Roglic G, Norris SL
doi: 10.7326/M18-1149.
RECOMMENDED
Type 1 DiabetesType 2 DiabetesPediatric Diabetes
Disordered Eating Behaviors in Youth and Young Adults With Type 1 or Type 2 Diabetes Receiving Insulin Therapy: The SEARCH for Diabetes in Youth Study
Diabetes Care.
Nip ASY, Reboussin BA, Dabelea D, Bellatorre A, Mayer-Davis EJ, Kahkoska AR, Lawrence JM, Peterson CM, Dolan L, Pihoker C, SEARCH for Diabetes in Youth Study Group
doi: 10.2337/dc18-2420.
Type 1 Diabetes
Risk factors for decline in renal function among young adults with type 1 diabetes
J Diabetes Complications.
Schwandt A, Bergis D, Denkinger M, Gollisch KSC, Sandig D, Stingl H, Zimny S, Holl RW
doi: 10.1016/j.jdiacomp.
COMMENTED
Diabetes - GeneralType 1 DiabetesType 2 DiabetesGlycemic Control
Random non-fasting C-peptide testing can identify patients with insulin-treated type 2 diabetes at high risk of hypoglycaemia
doi: 10.1007/s00125-017-4449-2.
Diabetes - GeneralType 2 DiabetesGlycemic Control
Changes in Diabetes Medication Regimens and Glycemic Control in Adolescents and Young Adults with Youth Onset Type 2 Diabetes: the SEARCH for Diabetes in Youth Study
Pediatr Diabetes.
Pinto CA, Stafford JM, Wang T, Shankar RR, Lawrence JM, Kim G, Pihoker C, D'Agostino RB Jr, Dabelea D
doi: 10.1111/pedi.12691.
Diabetes - General
Safety and efficacy of insulin degludec/liraglutide (IDegLira) added to sulphonylurea alone or to sulphonylurea and metformin in insulin-naïve people with Type 2 diabetes: the DUAL IV trial
Diabet Med.
Rodbard HW, Bode BW, Harris SB, Rose L, Lehmann L, Jarlov H, Thurman J; Dual Action of Liraglutide and insulin degludec (DUAL) IV trial investigators
doi: 10.1111/dme.13256.
COMMENTED
Diabetes - GeneralType 2 Diabetes
Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial
Lancet Diabetes Endocrinol.
Packer M, Claggett B, Lefkowitz MP, McMurray JJV, Rouleau JL, Solomon SD, Zile MR
doi: 10.1016/S2213-8587
COMMENTED
Type 2 DiabetesGlycemic Control
A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9)
★ 1
Recommended and commented by
Prof. emer. Dr Ulrich Keller, Faculty Member
doi: 10.2337/dc19-2232.
Type 2 Diabetes
Contribution of basal and postprandial hyperglycaemia in type 2 diabetes patients treated by an intensified insulin regimen: Impact of pump therapy in the OPT2mise trial
Diabetes Obes Metab.
Reznik Y, Habteab A, Castaneda J, Shin J, Joubert M
doi: 10.1111/dom.13398.